US Patent Issued to Quadram Institute Bioscience on June 16 for "Gut bacteria derived microvesicles for vaccine delivery" (British Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,877, issued on June 16, was assigned to Quadram Institute Bioscience (Norwich, Great Britain).

"Gut bacteria derived microvesicles for vaccine delivery" was invented by Regis Stentz (Norwich, Great Britain) and Simon Carding (Norwich, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a vaccine suitable for immunisation against influenza, plague or Y. pestis infection said vaccine comprising outer membrane vesicles (OMVs) and the plague vaccine including the V and/or F1 antigens of Y. pestis."

The patent was filed on Nov. 9, 2023, under Application No. 18/505,870.

*For further information, including image...